Logo image of ALSPT.PA

SPARTOO (ALSPT.PA) Stock Fundamental Analysis

EPA:ALSPT - Euronext Paris - Matif - FR00140043Y1 - Common Stock - Currency: EUR

0.349  -0.02 (-4.64%)

Fundamental Rating

2

ALSPT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 56 industry peers in the Specialty Retail industry. Both the profitability and financial health of ALSPT have multiple concerns. ALSPT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALSPT has reported negative net income.
ALSPT had a positive operating cash flow in the past year.
ALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFALSPT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M -5M -10M -15M -20M

1.2 Ratios

ALSPT has a Return On Assets of -1.22%. This is in the lower half of the industry: ALSPT underperforms 62.26% of its industry peers.
ALSPT's Return On Equity of -3.53% is on the low side compared to the rest of the industry. ALSPT is outperformed by 62.26% of its industry peers.
With a Return On Invested Capital value of 4.68%, ALSPT perfoms like the industry average, outperforming 58.49% of the companies in the same industry.
Industry RankSector Rank
ROA -1.22%
ROE -3.53%
ROIC 4.68%
ROA(3y)-1.7%
ROA(5y)N/A
ROE(3y)-5.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSPT.PA Yearly ROA, ROE, ROICALSPT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

ALSPT has a Operating Margin (2.27%) which is comparable to the rest of the industry.
ALSPT's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 52.09%, ALSPT is doing good in the industry, outperforming 79.25% of the companies in the same industry.
In the last couple of years the Gross Margin of ALSPT has remained more or less at the same level.
Industry RankSector Rank
OM 2.27%
PM (TTM) N/A
GM 52.09%
OM growth 3Y-21.22%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.16%
GM growth 5YN/A
ALSPT.PA Yearly Profit, Operating, Gross MarginsALSPT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 20 30 40 50

More info and screens

3

2. Health

2.1 Basic Checks

ALSPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for ALSPT remains at a similar level compared to 1 year ago.
Compared to 1 year ago, ALSPT has a worse debt to assets ratio.
ALSPT.PA Yearly Shares OutstandingALSPT.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M
ALSPT.PA Yearly Total Debt VS Total AssetsALSPT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

ALSPT has an Altman-Z score of 1.71. This is a bad value and indicates that ALSPT is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.71, ALSPT perfoms like the industry average, outperforming 45.28% of the companies in the same industry.
The Debt to FCF ratio of ALSPT is 5.66, which is a neutral value as it means it would take ALSPT, 5.66 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALSPT (5.66) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.53 indicates that ALSPT is somewhat dependend on debt financing.
The Debt to Equity ratio of ALSPT (0.53) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.66
Altman-Z 1.71
ROIC/WACC0.81
WACC5.8%
ALSPT.PA Yearly LT Debt VS Equity VS FCFALSPT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M -20M

2.3 Liquidity

A Current Ratio of 1.90 indicates that ALSPT should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.90, ALSPT belongs to the best of the industry, outperforming 83.02% of the companies in the same industry.
ALSPT has a Quick Ratio of 1.90. This is a bad value and indicates that ALSPT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ALSPT (0.62) is better than 60.38% of its industry peers.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 0.62
ALSPT.PA Yearly Current Assets VS Current LiabilitesALSPT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

2

3. Growth

3.1 Past

ALSPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.83%, which is quite impressive.
The Revenue has decreased by -8.67% in the past year.
ALSPT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.52% yearly.
EPS 1Y (TTM)39.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.36%
Revenue 1Y (TTM)-8.67%
Revenue growth 3Y1.52%
Revenue growth 5YN/A
Sales Q2Q%-10.49%

3.2 Future

The Earnings Per Share is expected to grow by 12.10% on average over the next years. This is quite good.
The Revenue is expected to decrease by -2.53% on average over the next years.
EPS Next Y57.89%
EPS Next 2Y-2.6%
EPS Next 3Y34.28%
EPS Next 5Y12.1%
Revenue Next Year-8.36%
Revenue Next 2Y-6.57%
Revenue Next 3Y-3.58%
Revenue Next 5Y-2.53%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALSPT.PA Yearly Revenue VS EstimatesALSPT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALSPT.PA Yearly EPS VS EstimatesALSPT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 -0.2 -0.3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ALSPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALSPT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALSPT.PA Price Earnings VS Forward Price EarningsALSPT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

98.11% of the companies in the same industry are more expensive than ALSPT, based on the Enterprise Value to EBITDA ratio.
96.23% of the companies in the same industry are more expensive than ALSPT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.58
EV/EBITDA 2.02
ALSPT.PA Per share dataALSPT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

A more expensive valuation may be justified as ALSPT's earnings are expected to grow with 34.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.6%
EPS Next 3Y34.28%

More info and screens

0

5. Dividend

5.1 Amount

ALSPT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SPARTOO

EPA:ALSPT (6/13/2025, 7:00:00 PM)

0.349

-0.02 (-4.64%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners35.83%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.38M
Analysts82
Price Target0.82 (134.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-14.29%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF 1.58
P/OCF 1.29
P/B 0.21
P/tB 0.25
EV/EBITDA 2.02
EPS(TTM)-0.07
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)0.22
FCFY63.29%
OCF(TTM)0.27
OCFY77.75%
SpS7.4
BVpS1.69
TBVpS1.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.22%
ROE -3.53%
ROCE 6.36%
ROIC 4.68%
ROICexc 6.03%
ROICexgc 6.93%
OM 2.27%
PM (TTM) N/A
GM 52.09%
FCFM 2.99%
ROA(3y)-1.7%
ROA(5y)N/A
ROE(3y)-5.09%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-32.98%
ROICexcg growth 5YN/A
ROICexc growth 3Y-32.29%
ROICexc growth 5YN/A
OM growth 3Y-21.22%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.16%
GM growth 5YN/A
F-Score6
Asset Turnover1.52
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 5.66
Debt/EBITDA 1.8
Cap/Depr 15.18%
Cap/Sales 0.68%
Interest Coverage 250
Cash Conversion 54.21%
Profit Quality N/A
Current Ratio 1.9
Quick Ratio 0.62
Altman-Z 1.71
F-Score6
WACC5.8%
ROIC/WACC0.81
Cap/Depr(3y)33.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.31%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.36%
EPS Next Y57.89%
EPS Next 2Y-2.6%
EPS Next 3Y34.28%
EPS Next 5Y12.1%
Revenue 1Y (TTM)-8.67%
Revenue growth 3Y1.52%
Revenue growth 5YN/A
Sales Q2Q%-10.49%
Revenue Next Year-8.36%
Revenue Next 2Y-6.57%
Revenue Next 3Y-3.58%
Revenue Next 5Y-2.53%
EBIT growth 1Y31.86%
EBIT growth 3Y-20.02%
EBIT growth 5YN/A
EBIT Next Year192.86%
EBIT Next 3Y62.43%
EBIT Next 5Y42.67%
FCF growth 1Y134.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y149.41%
OCF growth 3Y30.84%
OCF growth 5YN/A